The US Food and Drug Administration (FDA) on Wednesday published draft guidance on the US Pharmacopoeial Convention Pending Monograph Process (USP-PMP), outlining how sponsors can revise or create new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results